Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clive P Page

Showing results (31-40 of 139) with videos related to

Pageof 14
Sort By:
Current Opinion in Pharmacology|May 14, 2004
Shooting for PARs in lung diseasesJames D Moffatt, Clive P Page, Geoffrey J Laurent
Pharmacological Reviews|May 22, 2012
Pharmacology and therapeutics of bronchodilatorsMario Cazzola, Clive P Page, Luigino Calzetta, et al.
Expert Opinion on Drug Metabolism & Toxicology|December 4, 2013
Use of indacaterol for the treatment of COPD: a pharmacokinetic evaluationMario Cazzola, Luigino Calzetta, Clive P Page, et al.
Pharmacology & Therapeutics|August 8, 2007
Getting to the heart of asthma: can "beta blockers" be useful to treat asthma?Richard A Bond, Domenico Spina, Sergio Parra, et al.
Expert Opinion on Therapeutic Targets|October 3, 2007
Targeting systemic inflammation: novel therapies for the treatment of chronic obstructive pulmonary diseaseMario Cazzola, Chiara Ciaprini, Clive P Page, et al.
The European Respiratory Journal|April 13, 2012
Emerging anti-inflammatory strategies for COPDMario Cazzola, Clive P Page, Luigino Calzetta, et al.
American Journal of Respiratory and Critical Care Medicine|January 26, 2013
β2-agonist therapy in lung diseaseMario Cazzola, Clive P Page, Paola Rogliani, et al.
Pulmonary Pharmacology & Therapeutics|January 15, 2005
The effect of selective phosphodiesterase isoenzyme inhibition on neutrophil function in vitroN A Jones, V Boswell-Smith, R Lever, et al.
Pharmacological Reviews|December 17, 2015
Pharmacology of Heparin and Related DrugsBarbara Mulloy, John Hogwood, Elaine Gray, et al.
British Journal of Pharmacology|November 3, 2020
Update on animal models for COVID-19 researchSimon J Cleary, Mélia Magnen, Mark R Looney, et al.
Pageof 14

Showing results (31-40 of 139) with videos related to

Sort By:
Pageof 14
Current Opinion in Pharmacology|May 14, 2004
Shooting for PARs in lung diseasesJames D Moffatt, Clive P Page, Geoffrey J Laurent
Pharmacological Reviews|May 22, 2012
Pharmacology and therapeutics of bronchodilatorsMario Cazzola, Clive P Page, Luigino Calzetta, et al.
Expert Opinion on Drug Metabolism & Toxicology|December 4, 2013
Use of indacaterol for the treatment of COPD: a pharmacokinetic evaluationMario Cazzola, Luigino Calzetta, Clive P Page, et al.
Pharmacology & Therapeutics|August 8, 2007
Getting to the heart of asthma: can "beta blockers" be useful to treat asthma?Richard A Bond, Domenico Spina, Sergio Parra, et al.
Expert Opinion on Therapeutic Targets|October 3, 2007
Targeting systemic inflammation: novel therapies for the treatment of chronic obstructive pulmonary diseaseMario Cazzola, Chiara Ciaprini, Clive P Page, et al.
The European Respiratory Journal|April 13, 2012
Emerging anti-inflammatory strategies for COPDMario Cazzola, Clive P Page, Luigino Calzetta, et al.
American Journal of Respiratory and Critical Care Medicine|January 26, 2013
β2-agonist therapy in lung diseaseMario Cazzola, Clive P Page, Paola Rogliani, et al.
Pulmonary Pharmacology & Therapeutics|January 15, 2005
The effect of selective phosphodiesterase isoenzyme inhibition on neutrophil function in vitroN A Jones, V Boswell-Smith, R Lever, et al.
Pharmacological Reviews|December 17, 2015
Pharmacology of Heparin and Related DrugsBarbara Mulloy, John Hogwood, Elaine Gray, et al.
British Journal of Pharmacology|November 3, 2020
Update on animal models for COVID-19 researchSimon J Cleary, Mélia Magnen, Mark R Looney, et al.
Pageof 14